OREXIGEN THERAPEUTICS INC's ticker is OREXXXXX and the CUSIP is 686164104. A total of 66 filers reported holding OREXIGEN THERAPEUTICS INC in Q2 2016. The put-call ratio across all filers is 4.92 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $13,000 | -81.9% | 23,883 | -42.9% | 0.00% | – |
| Q4 2015 | $72,000 | -62.1% | 41,831 | -53.6% | 0.00% | – |
| Q3 2015 | $190,000 | -37.1% | 90,244 | +47.7% | 0.00% | -100.0% |
| Q2 2015 | $302,000 | -36.3% | 61,085 | +0.8% | 0.00% | 0.0% |
| Q1 2015 | $474,000 | +28.8% | 60,589 | -0.1% | 0.00% | 0.0% |
| Q4 2014 | $368,000 | +35.8% | 60,647 | -4.5% | 0.00% | 0.0% |
| Q3 2014 | $271,000 | -34.4% | 63,521 | -5.0% | 0.00% | 0.0% |
| Q2 2014 | $413,000 | +3.2% | 66,856 | +8.7% | 0.00% | 0.0% |
| Q1 2014 | $400,000 | +61.3% | 61,509 | +39.7% | 0.00% | 0.0% |
| Q4 2013 | $248,000 | -9.8% | 44,032 | -1.9% | 0.00% | 0.0% |
| Q3 2013 | $275,000 | +13.2% | 44,871 | +8.0% | 0.00% | 0.0% |
| Q2 2013 | $243,000 | – | 41,564 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 3,000,000 | $5,160,000 | 4.58% |
| Foresite Capital Management II, LLC | 6,225,049 | $10,707,000 | 3.59% |
| Scale Management, LLC | 1,312,575 | $2,258,000 | 3.46% |
| NEA Management Company, LLC | 3,709,000 | $6,379,000 | 0.41% |
| Cheyne Capital Management (UK) LLP | 413,200 | $709,000 | 0.38% |
| Rhenman & Partners Asset Management AB | 1,189,000 | $2,045,000 | 0.31% |
| SAMLYN CAPITAL, LLC | 6,160,417 | $10,596,000 | 0.22% |
| Rock Springs Capital Management LP | 1,650,000 | $2,838,000 | 0.22% |
| Palo Alto Investors LP | 1,673,024 | $2,878,000 | 0.16% |
| GLOBEFLEX CAPITAL L P | 295,000 | $507,000 | 0.14% |